Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition.
Deepak BabuAnwita MudirajNeera YadavChandrashekhar Y B V KManas PanigrahiPhanithi Prakash BabuPublished in: Cellular oncology (Dordrecht) (2021)
Our data revealed (i) a clinical association of the EMT-like process with glioma malignancy and a poor survival and (ii) an anticancer and temozolomide sensitizing effect of rabeprazole by repressing EMT.